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6ABSTRACT
Leuconostocs are lactic acid bacteria used as starters in food fermentations. They can also
be spoilage bacteria, especially in vacuum packed meat products. Many Leuconostocs
produce antimicrobial peptides, also known as bacteriocins. Leuconostoc bacteriocins are
usually small, less than 10 kDa non-modified peptides, which are secreted by dedicated
transporters. These bacteriocins kill many different bacteria, including strains of
Enterococcus, Listeria, and Staphylococcus genera. Sensitivity to bacteriocins is usually
dependent on a specific receptor on the target cell membrane. On Listeria cell membrane,
mannose-phosphotransferase system Man-PTS has been shown to be the target for
bacteriocins leucocins A and C from Leuconostoc. These class IIa bacteriocins bind to the
subunit IIC (MptC) of Man-PTS and open the transporter, which leads to cell leakage and
eventually cell death. Bacteriocin producers express specific immunity proteins, which
protect the producer cells by blocking the transporter pore.
In this doctoral dissertation, the bacteriocins produced by Leuconostoc carnosum 4010
were studied. The strain 4010 is a commercial protective culture for vacuum packaged
meat products. The strain produces two antilisterial bacteriocins, leucocins A and C. In
this study, the strain was found to produce a third bacteriocin, leucocin B, which is active
against some Leuconostoc and Weissella strains. Genes required for the production of the
three leucocins were characterised. The leucocin genes were arranged in operons on two
native plasmids. A single ABC-transporter was found in the strain 4010 and was believed
to carry out the bacteriocin secretion for all three leucocins. Immediately downstream of
the leucocin genes lcnA, lebB, and lecC, putative immunity genes lcnB, lebI, and lecI were
found. The immunity mechanisms of leucocin C was studied by expressing the lecI gene
in L. monocytogenes. LecI producing Listeria was less sensitive to the leucocin C, showing
the immunity function of LecI. By cloning the leucocin genes in plasmid vectors, active
bacteriocins were produced in heterologous hosts Escherichia coli and Lactococcus lactis.
Finally, leucocins A and C were used in a Lc. lactis genome editing method developed in
this study. It has been shown that expression of Listerial mptC gene in Lc. lactis renders
the host sensitive to class IIa bacteriocins. In this doctoral study, a counterselection method
based on bacteriocin sensitivity was developed to select the loss of a plasmid. Listerial
mptC gene was cloned in an integration vector aiming at a chromosomal deletion, and the
plasmid was transferred into Lc. lactis. When the bacteriocin sensitive integrants were
cultured with leucocin A or C, only the cells which had lost the mptC-plasmid through a
second homologous recombination could survive. The second recombination may also
cause the desired deletion. With this bacteriocin counterselection method, fragments up to
35 kb were deleted from Lc. lactis chromosome.
The results obtained from this doctoral study provide further knowledge of Leuconostoc
bacteriocins and their scientific use.
7TIIVISTELMÄ (abstract in Finnish)
Leuconostoc-suvun bakteerit ovat elintarvikkeiden hapatteina käytettyjä
maitohappobakteereita. Leukonostokit voivat olla myös pilaajabakteereita, erityisesti
lihatuotteissa. Monet Leukonostokit tuottavat antimikrobisia peptidejä eli bakteriosiineja.
Leukonostokkien tuottamat bakteriosiinit ovat lähes aina pieniä, alle 10 kDa kokoisia
modifioimattomia peptidejä, jotka eritetään spesifisillä kuljettimilla ulos solusta. Ne
tappavat monia erilaisia bakteereita, kuten Enterococcus, Listeria, ja Staphylococcus –
sukujen kantoja. Bakteerien herkkyys bakteriosiineille perustuu yleensä spesifiseen
reseptoriin solun pinnalla. Listerian solukalvolla olevan mannoosi-fosfotransferaasi Man-
PTS -kuljettimen on osoitettu toimivan reseptorina mm leukonostokkien tuottamille
leukosiini A:lle ja C:lle. Nämä luokan IIa bakteriosiinit tarttuvat Man-PTS –kuljettimen
alayksikkö IIC:hen (MptC), ja aiheuttavat kuljettimen avautumisen. Avoin kuljetin toimii
vuotavana reikänä solukalvolla, jolloin solu kuolee. Bakteriosiinien tuottajilla on itsellään
erityinen immuniteettiproteiini, joka suojaa tuottajasolua tukkimalla avoimen kuljettimen.
Tässä väitöstyössä tutkittiin Leuconostoc carnosum 4010 –bakteerikannan tuottamia
bakteriosiineja. Ln. carnosum 4010 on vakuumipakattujen lihatuotteiden kaupallinen
suojaviljelmäkanta, joka estää L. monocytogenes –bakteerin kasvua tuottamalla kahta
Listeria-aktiivista bakteriosiinia, leukosiineja A ja C. Työssä osoitettiin 4010-kannan
tuottavan myös kolmatta bakteriosiinia, leukosiini B:tä, joka tappaa mm Leuconostoc- ja
Weissella -bakteerikantoja. Työssä karakterisoitiin näiden kolmen bakteriosiinin tuottoon
tarvittavat geenit 4010-kannassa. Leukosiinigeenien osoitettiin olevan järjestäytyneinä
operoneiksi kahdessa eri plasmidissa. Bakteriosiinien erittämiseen löytyi vain yksi kuljetin,
jonka uskotaan erittävän kaikkia kolmea leukosiinia. Kaikkien leukosiinigeenien, lcnA,
lebB, ja lecC, perässä oli todennäköiset immuniteettigeenit lcnB, lebI, ja lecI. Leukosiini
C:n immuniteettimekanismia tutkittiin ilmentämällä lecI-geeniä L. monocytogenes –
kannassa. LecI:tä tuottava Listeria sieti paremmin bakteriosiinia, mikä osoitti LecI:n
olevan leukosiini C:n immuniteettiproteiini. Aktiivisia leukosiineja tuotettiin
heterologisissa Escherichia coli ja Lactococcus lactis –isäntäkannoissa kloonaamalla
bakteriosiinigeenit plasmidivektoreihin. Lopuksi leukosiineja A ja C käytettiin tässä
työssä kehitetyssä Lc. lactis –bakteerin genominmuokkausmenetelmässä. Aiemmin on
osoitettu, että Listerian mptC-geenin ilmentäminen Lc. lactis –bakteerissa tekee
laktokokkisolusta bakteriosiineille herkän. Tätä ominaisuutta hyödynnettiin
vastaselektiossa, jossa estetään plasmidin sisältävien solujen kasvu. Listerian mptC-geeni
liitettiin kromosomaalista deleetiota varten rakennettuun integraatiovektoriin, joka
siirrettiin Lc. lactis –soluihin. Vektorin integraatio kromosomiin tekee kannasta
bakteriosiiniherkän. Kasvatettaessa integranttia leukosiini A:n tai C:n kanssa, vain ne solut,
joista mptC-integraatiovektori on toisen homologisen rekombinaation kautta poistunut,
pystyvät kasvamaan. Vektorin poistuessa tapahtuu mahdollisesti myös haluttu
kromosomaalinen deleetio. Tämän bakteriosiini-vastaselektiomenetelmän avulla
poistettiin 17-35 kb kokoisia paloja Lc. lactis –kannan kromosomista.
Tämän työn tulokset lisäävät tietoamme maitohappobakteerien antimikrobisista
ominaisuuksista ja bakteriosiinien käyttömahdollisuuksista tieteellisissä sovelluksissa.
8INTRODUCTION
1 Lactic acid bacteria
Lactic acid bacteria (LAB) constitute a diverse group of Gram-positive (Gram+) bacteria
which produce lactic acid from the fermentation of available carbon sources, e.g. glucose
(Axelsson 2004). LAB can quickly lead to the acidification (lower than pH 4.0) of food
materials due to the production lactic acid, thus they effectively prevent the outgrowth of
almost all potential spoilage microorganisms. LAB can also give food characteristic
textures, flavours and aromas. Therefore, LAB are widely used in fermentation industry
all over the world, with the most applications of LAB in the dairy sector of the food
industries.
Depending on the sugar fermentation patterns, LAB are divided into two broad metabolic
categories: homofermentative and heterofermentative. Representative homofermentative
LAB include Lactobacillus, Lactococcus, Enterococcus, Pediococcus and Streptococcus.
In the presence of excess glucose and limited oxygen, homofermentative LAB catabolise
one mole of glucose into two moles of pyruvate, which in the end after oxidation of NADH
are reduced merely to lactic acid. Whereas obligate heterofermentative LAB yield
theoretically equimolar quantities of CO2, ethanol and lactic acid from one mole of glucose.
This category includes Fructobacillus, Leuconostoc, Oenococcus, Weissella, and certain
Lactobacilli (Axelsson 2004).
Lactococcus lactis is a model LAB widely used for industrial production of fermented
dairy products, such as milk, cheese and yoghurt. Extensive studies have been done to
increase the efficiency of Lc. lactis for food industry. Genetically modified Lc. lactis has
also been used alive to treat human inflammatory bowel disease (Braat et al. 2006). Lc.
lactis genome editing tools are in good need for a better exploiting the microorganism.
1.1 The genus of Leuconostoc
Leuconostoc species are LAB that are commonly associated with foods and used as flavour
forming culture in fermentations, for example, in Finnish traditional milk product Viili.
Morphologically, leuconostocs are Gram+ cocci in chains. Leuconostocs are closely
related to Fructobacillus, Oenococcus and Weissella species, and together they are
commonly known as the Leuconostocaceae family of LAB. The Leuconostoc sensu stricto
includes, at the time of writing, 13 validly published species names (Table 1) .
Table 1. Leuconostoc species and their sources of identification, according to LPSN bacterio.net
(2015).
Species Source Reference
Ln. carnosum chilled meat Shaw and Harding (1989)
Ln. citreum honey-dew of rye ear Farrow et al. (1989)
Ln. fallax sauerkraut Martinez-Murcia and Collins (1991)
Ln. gelidum* chilled meat Shaw and Harding (1989)
Ln. holzapfelii coffee fermentation De Bruyne et al. (2007)
9Ln. inhae kimchi Kim et al. (2003)
Ln. kimchii kimchi Kim et al. (2000)
Ln. lactis milk Garvie (1986)
Ln. mesenteroides sugar beet solution Garvie (1986)
Ln. miyukkimchii brown algae kimchi Lee et al. (2012)
Ln. palmae palm wine Ehrmann et al. (2009)
Ln. pseudomesenteroides cane juice Farrow et al. (1989)
Ln. rapi sous-vide rutabaga Lyhs et al. (2015)
* Ln. gasicomitatum is  now  reclassified  as Ln. gelidum ssp. gasicomitatum. Ln. oenos is  reclassified  as
Oenococcus oeni, hence no longer belongs to Leuconostoc (Dicks et al. 1995). Similarly, Ln. paramesenteroides
is renamed as Weissella paramesenteroides (Collins et al. 1993).
1.2 Leuconostocs in food production
Like other LAB, leuconostocs also play important roles in food fermentation and
preservation. In the 1990s, people started to realise that a buttery aroma in many dairy
products was associated with leuconostocs (Dessart and Steenson 1995; Thunell 1995).
For example, during cheese ripening, low concentration of citrate in cheese curd could be
metabolised by leuconostocs together with lactococci to produce a number of volatile
flavour compounds (McSweeney and Sousa 2000). For instance, Ln. mesenteroides is used
as flavour forming culture in the Finnish fermented dairy product Viili, which has an
iconic slimy texture from Lc. lactis (Kahala et al. 2008; Sundman 1953). Various Ln.
mesenteroides and Ln. citreum strains have been found to improve fermentation of Korean
pickled vegetables kimchi (Lee et al. 2015). Ln. mesenteroides is responsible for souring
and leavening Indian fermented food idli or dosa (Mukherjee et al. 1965; Soni and Sandhu
1991). Leuconostocs are also used as protective culture as they can prolong the shelf life
and increase safety of food products by producing antimicrobial compounds including
hydrogen peroxide and antimicrobial peptides (AMPs) i.e., bacteriocins (Holzapfel et al.
1995; Säde 2011). Because of the bacteriocin production, Ln. carnosum 4010 was used as
protective culture in refrigerated vacuum packaged meat products (Budde et al. 2003).
More detailed information regarding bacteriocins produced by leuconostocs is presented
in the introduction chapter 2.3 Leuconostoc bacteriocins. Applications of Leuconostoc
bacteriocins can be found in chapter 4 LAB bacteriocin applications.
Nevertheless, in addition to the numerous benefits leuconostocs have brought to the food
industry, they can also be responsible for the spoilage of cold-stored foods, particularly
meat products. Different Leuconostoc species can cause various defects in meat and
vegetable products, such as blowing, off-odour, sour odour, slime, discolouration and
exudation (Björkroth et al. 2000; Cai et al. 1998; Diez et al. 2008; Korkeala et al. 1988;
Torriani et al. 1999). Ln. mesenteroides for example was found responsible for greening
colour and slime of cooked bacon through sugar fermentations and degradation of nitrogen
compounds (Comi et al. 2016). The blowing of packages is due to CO2 accumulation
caused by the Ln. gelidum catabolism of carbohydrates, while unwanted buttery off-
odours were because of diacetyl/acetoin formation by Ln. gelidum (Jääskeläinen et al.
2015; Vihavainen and Björkroth 2007; Vihavainen et al. 2008).
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2 LAB bacteriocins and how to find them
There have been several reports of antimicrobial activity of LAB, due to the presence of
organic acids, hydrogen peroxide or other produced chemicals. In the past century, it has
gradually become clear that LAB combat microorganisms by at least one other mechanism,
namely by secretion of AMPs. These ribosomally synthesised AMPs produced by bacteria
are called bacteriocins. Many LAB, for example Carnobacterium, Enterococcus,
Lactococcus, Lactobacillus, Leuconostoc, and Pediococcus species have been shown to
produce and secrete bacteriocins against competing microorganisms (Alvarez-Sieiro et al.
2016). There have been lots of fundamental and applied researches on LAB bacteriocins,
due to their potential applications as biopreservatives in food and food products to inhibit
the growth of food-borne pathogens and to prevent food spoilage. In general, LAB
bacteriocins kill target cells by forming pores on the cell membrane, which leads to the
cell leakage and eventually cell death (Cotter et al. 2013).
The inhibitory effect of lactococcal substance on the growth of other LAB can date back
in the late 1920s (Rogers and Whittier 1928), shortly after the discovery of “colicin” from
the Gram-negative (Gram-) Escherichia coli (Gratia 1925). The first LAB bacteriocin was
named as nisin (group N Streptococcus Inhibitory Substance, -in ending referring to an
antibiotic) (Mattick et al. 1947). In the following 40 some years, nisin has been accepted
as a safe food additive by World Health Organisation (1969) and European Economic
Community (1983), and affirmed as generally recognised as safe and used in cheese
spreads in the United States (FDA 1988). Nisin is a great example in terms of the AMP
developing pattern from antimicrobial activity to legal approval and to final commercial
application. Yet, although tremendous amount of bacteriocins are discovered every year,
not single one of them has been accepted like nisin (Cotter et al. 2013).
A study of bacteriocins from LAB has historically started with the discovery of the
antimicrobial activity of LAB isolated from various sources, of which especially
fermented food products have been the most common places for bacteriocinogenic LAB.
This discovery pattern is still common nowadays. For example, the latest identified
enterocin NKR-5-3 was purified and characterised from Enterococcus faecium NKR-5-3
isolated from Thai fermented fish (Ishibashi et al. 2012). From traditional Chinese
fermented vegetables, Lb. plantarum 163 was isolated and was found to produce
plantaricin 163 which was mainly active against Staphylococcus aureus and Bacillus
cereus (Hu et al. 2013). In the discovery process, preliminary antimicrobial activity from
a strain is tested on indicator lawn. Then the bioactive compound produced by this certain
strain is purified from bacterial culture, and the protein nature of the compound is
confirmed. Afterwards, the structures of the bacteriocin are then studied, e.g. through
amino acid (aa) sequencing and mass spectrometry. Genetic studies of the bacteriocin are
often conducted at the same time.
Nowadays, as the sequencing technology advances, more and more bacterial genomes
have become available. The pace of bacteriocin discovery has also been accelerated.
Though genome mining, significant amount of putative bacteriocin genes can be identified
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together with their biosynthetic mechanisms (Wang et al. 2013; Zhao and Kuipers 2016).
It is crucial to confirm the antimicrobial activity of a putative bacteriocin through various
biochemical methods. Structural studies are normally followed. For example, the
discovery of lichenicidin was a successful story through mining Bacillus licheniformis
genome for LanM proteins (Begley et al. 2009). Many internet based mining tools have
been developed for such purpose, such as BAGEL3 http://bagel.molgenrug.nl/ (van Heel
et al. 2013), which can analyse DNA sequences in FASTA format and give possible ORFs
for both modified and non-modified putative bacteriocins.
Yet to find an optimal condition to isolate naturally expressed AMPs from any given
microorganism can be very challenging. Therefore, with the help of nisin expression and
modification system, van Heel et al. (2016) were able to overexpress putative lantibiotics
obtained from genome mining. These obtained lantibiotics were shown to display high
antimicrobial activity against various indicator strains including methicillin-resistant S.
aureus (MRSA) (van Heel et al. 2016).
2.1 Classification of bacteriocins
According to Bactibase, the online database for bacteriocins (Hammami et al. 2007), there
are 229 characterised bacteriocins by the time of writing. Moreover, with the use of
BAGEL3, 238 complete LAB genomes were analysed and another 785 putative
bacteriocin gene clusters were proposed (Alvarez-Sieiro et al. 2016). To date, many
classification schemes have been proposed for the better understanding of bacteriocin
basics.
Since the first classification system of LAB bacteriocins by Klaenhammer (1993), many
modified schemes have been suggested. A structure-based classification for Gram+
bacteriocins can be as many as 12 groups (Zouhir et al. 2010). In general agreement,
bacteriocins can be divided into three classes, excluding complex protein containing lipid
or carbohydrate moieties (Cotter et al. 2013).
Class I bacteriocins are small (<10 kDa), heat-stable, membrane-active peptides, which
have gone through post-translational modifications. These bacteriocins are ribosomally
synthesised as inactive form. Only after post-translational enzymatic modifications to
form unusual amino acids and structures, they can become biologically active (Alvarez-
Sieiro et al. 2016). According to their structures, lantibiotics alone can be even divided
into 11 subgroups (Cotter et al. 2005).
Class II bacteriocins are heat-stable small peptides (<10 kDa), which formation does not
require any modification. There have been unsettled sub-divisions in this class due to
many unique characteristics, especially, regarding the bacteriocins with cyclic structures.
Some have seen circular bacteriocins as an individual class, e.g., class V in addition to
Klaenhammer (1993)’s four-class scheme (Kemperman et al. 2003), or class IV with
modifications based on Cotter et al. (2005)’s three-class system (Heng and Tagg 2006;
Nes et al. 2007). In addition, Franz et al. (2007) even suggested a whole new classification
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scheme based on the variety of enterocins, with cyclic peptides being class III in the
enterocin scheme. Leaderless bacteriocins were listed in their own subgroup class IId by
Nes et al. (2007). In their classification scheme, Nes et al. (2007) also separated the AMPs
derived from larger proteins from the others and grouped them in class IIe.
Class III bacteriocins are generally considered to be large (>10 kDa) thermo-labile AMPs,
including bacteriolysins and non-lytic bacteriocins (Alvarez-Sieiro et al. 2016), despite of
the variations in the grouping of cyclic peptides (Alvarez-Sieiro et al. 2016; Cotter et al.
2013; Heng and Tagg 2006; Perez et al. 2014; Yang et al. 2014).
In this doctoral thesis, the classification of LAB bacteriocins is modified according to
Alvarez-Sieiro et al. (2016), Arnison et al. (2013), and Nissen-Meyer et al. (2009) as
shown in Table 2. Yet it is safe to say that, as more novel bacteriocins are expected to be
discovered with the help of advancing technology, the classification scheme is inevitably
to evolve accordingly.
Table 2. Proposed classification of LAB bacteriocins, modified according to the schemes of
Alvarez-Sieiro et al. (2016), Arnison et al. (2013), and Nissen-Meyer et al. (2009).
Group Descriptions Examples Producers References
Class I Small (<10 kDa), heat-stable, modified bacteriocins
Ia Lantibiotics/
lantipeptides
Nisin A Lc. lactis Gross and Morell
(1971)
Lacticin 481 Lc. lactis
CNRZ 481
Piard et al. (1993)
Ib Sactibiotics Subtilosin A Bacillus
subtilis 168
Babasaki et al.
(1985)
Ic Linear azol(in)e-
containing peptides
Streptolysin S Streptococcus
pyogenes
Todd (1938)
Id Glyocins Sublancin 168 Bacillus
subtilis 168
Paik et al. (1998)
Class II Small (<10 kDa), heat-stable, unmodified bacteriocins
IIa Pediocin-like
bacteriocins
Leucocin C Ln. carnosum
4010
Budde et al. (2003)
Pediocin Pediococcus
acidilactici
PAV-1.0
Henderson et al.
(1992)
IIb Two-peptide
bacteriocins
Lactococcin G Lc. lactis
LMG 2081
Nissen-Meyer et al.
(1992)
IIc Circular
bacteriocins
Lactocyclicin Q Lactococcus
sp. QU 12
Sawa et al. (2009)
IId Non-pediocin-like
single linear
bacteriocins
Lacticin Q Lc. lactis QU
5
Fujita et al. (2007)
Lactococcin A Lc. lactis ssp.
cremoris
LMG 2130
Holo et al. (1991)
Class III Large (>10 kDa), heat-labile bacteriocins
IIIa Bacteriolysin Enterolysin A En.  faecalis
LMG 2333
Nilsen et al. (2003)
IIIb Non-lytic Helveticin J Lb. helveticus
481
Joerger and
Klaenhammer
(1986)
13
2.2 Class II: unmodified bacteriocins
This thesis focuses on Leuconostoc bacteriocins, all of which belong to the class II. For
that reason, unmodified bacteriocins are discussed in more detail here.
Class II bacteriocins composes a vast amount of non-modified single linear heat-stable
small AMPs with molecular mass less than 10 kDa. Class II bacteriocins often have a
narrow antimicrobial spectrum, and are normally most active against closely related
bacteria, which likely occur in the same ecological niche. It has been well established that
class II bacteriocins kill target cell by forming pores or interfering with the integrity of the
cell membrane (Eijsink et al. 2002).
Genes involved in class II bacteriocins synthesis are arranged in operons located in either
the chromosome or the plasmids. Most class II bacteriocins are plasmid-borne. Yet there
are a few examples which genetic determinants are found on bacterial chromosome,
including enterocins A and B produced by En. faecium strains (Aymerich et al. 1996;
Franz et al. 1999), divercin V41 from Carnobacterium divergens (Metivier et al. 1998),
carnobacteriocin BM1 (Quadri et al. 1994), and lactacin B from Lb. acidophilus PA3
(Barefoot and Klaenhammer 1983). Lactacin F is chromosomally encoded on a
conjugative transposon that is mobilized as a large extrachromosomal element (Muriana
and Klaenhammer 1987). Most of class II bacteriocins possess N-terminal leader sequence,
which is recognised by a dedicated transporter during the process of bacteriocin secretion.
The most common leader sequence has two glycine residues (GG) at the positions -1 and
-2 immediately before the cleavage site, and is cleaved off by ABC transporter when
crossing the cytoplasmic membrane (Nes et al. 1996).
To date, at least 98 class II bacteriocins from LAB have been isolated and characterised,
according to Bactibase, Nissen-Meyer et al. (2010), Maqueda et al. (2008), and Iwatani et
al. (2011). Due to their unique features, such as structure, subgrouping is proposed
according to various criteria (Table 2 on page 11), although with increased knowledge it
has become apparent that classification need to be modified when more bacteriocins are
discovered. In this thesis, I followed the 4-subgroup scheme: IIa pediocin-like, IIb two-
peptide, IIc circular, and IId single, linear, non pediocin-like bacteriocins.
2.2.1 Class IIa pediocin-like
Class IIa bacteriocins are often called pediocin-like bacteriocins, as the first well-studied
member in this group is pediocin. These bacteriocins have common mode of action and
are best known for their antimicrobial activity against food-borne pathogen Listeria
monocytogenes. Bacteriocins in this group contain an N-terminal consensus sequence
(YGNGV/L) and at least one C-terminal disulphide bridge formed by two cysteines. So
far, there are 42 bacteriocins included in the class IIa, including new members like
bacteriocin L-1077 from Lb. salivarius (Svetoch et al. 2011), and weissellin A from
Weissella paramesenteroides DX (Papagianni and Papamichael 2011).
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In general, bacteriocin genetic determinants are organised in one or a few operons and
transcribed independently (Drider et al. 2006). For a functional production of class IIa
bacteriocins, at least four genes are needed (Ennahar et al. 2000). These genes are: 1) the
structural gene encoding bacteriocin precursor; 2) the immunity gene encoding immunity
protein to protect producer from its own bacteriocin; 3) one or two genes encoding ATP-
binding cassette (ABC) transporter for bacteriocin secretion; 4) a gene encoding an
accessory protein necessary for bacteriocin secretion. Instead of using ABC transporter, a
few class IIa bacteriocins such as bacteriocin 31 (Tomita et al. 1996), enterocin P (Cintas
et al. 1997), and listeriocin743 (Kalmokoff et al. 2001), are secreted through sec-
dependent pathway.
On the cell membrane of target bacteria, a receptor responsible for the bacteriocin binding
has been identified to be the proteins of mannose phosphotransferase system (Man-PTS).
These sugar permeases help the cells with intake and phosphorylation of mannose and
glucose (Postma et al. 1993). In addition to the general PTS enzyme I (EI), Man-PTS also
possesses a carbohydrate-specific protein complex, i.e., enzyme II (EII), composed of four
subunits IIA, IIB, IIC and IID. The individual transmembrane proteins (IIC and IID) form
a carbohydrate-specific translocation channel (Postma et al. 1993).
The  expression  of  Man-PTS  in L. monocytogenes and En. faecalis is regulated by the
sigma factor σ54 encoded by the regulatory gene rpoN (Dalet et al. 2001; Robichon et al.
1997). Lack of σ54 and subsequently inactivation of mpt genes led to the bacteriocin
resistance (Dalet et al. 2001; Héchard et al. 2001). By gene deletion and complementation,
the IIC and IID of Man-PTS have been identified as the crucial anchor molecule for the
class IIa bacteriocins to bind (Diep et al. 2007; Fimland et al. 2005). Later, an extracellular
loop and its flanking regions (40 aa in total) located in the Man-PTS IIC were found
essential for the specific recognition by class IIa bacteriocin (Kjos et al. 2010). Subunit
IIC alone could already confer the sensitivity when listerial mptC was  expressed  in
Lactococcus with an intact native IID encoded by ptnD  (Wan et al. 2016). The function
of IID was suspected to support the structure of Man-PTC and help IIC fold correctly in
the membrane, facilitating the bacteriocin binding (Kjos et al. 2011a).
As in the N-terminal sequence of class IIa bacteriocins, there is a conserved motif
(YGNGVxCxxxxCxVxWxxA) shared among all the group members, one might suspect
that the N-terminal would be involved in target interaction. However, hybrid AMPs with
N- and C-termini from different class IIa bacteriocins showed similar antimicrobial
spectrum as that of the C-termini donors. The results indicated that the significantly varied
C-termini is also responsible for the bacteriocin to specifically target the cells (Fimland et
al. 1996; Johnsen et al. 2005). This obvious conflict leads to a possible explanation. The
N-terminal β-sheet would first interact with the extracellular loop of the Man-PTS IIC
protein, that enables the C-terminal α-helix engaging a helix-helix interaction with the
Man-PTS regardless of the aa sequence (Kjos et al. 2011a). As the divergence of
bacteriocin C-termini, it explains why immunity protein, various in sequence yet possesses
a bundle of four antiparallel helix, could specifically bind to the cognate bacteriocin-
receptor complex (Figure 1 on page 15).
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Figure 1. Proposed model of action (a) and immunity (b) of class IIa bacteriocins. The N-terminal β-sheet of the bacteriocin (red) binds to an extracellular loop (a) of the Man-PTS IIC
domain (left). Then, the C-terminal helix interacts with transmembrane helices of the IIC (right) causing conformational changes, thereby resulting in the pore formation and eventually
cell death. In immune cells (b), the bacteriocin mediates the same conformational changes, but the pore is blocked by a specific immunity protein (dark blue) which interacts with both IIC
and IID of the receptor-bacteriocin complex. Adapted from Kjos et al. (2011a).
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In order not to get killed by their own bacteriocins, bacteria have developed a self-
protection system called immunity. In most bacteriocinogenic bacteria, self-immunity is
accomplished by designated immunity protein encoded by the immunity gene located next
to and co-expressed with the bacteriocin structural gene(s) (Cotter et al. 2005). Class IIa
bacteriocins target the mannose phosphoransferase system on sensitive cells. Immunity
protein protects the cells from Man-PTS targeting bacteriocins by blocking the pore
formed by the bacteriocin from inside of the cells (Kjos et al. 2011a). Man-PTS IID has
been shown to be indispensable, together with IIC, in the specific recognition between the
bacteriocin immunity protein and the bacteriocin-receptor complex (Zhou et al. 2016). In
comparative studies of immunity proteins, Fimland et al. (2002a) suggested three groups
of immunity proteins to class IIa bacteriocins with clear similarities spanning along the
sequence, which makes cross-immunity possible.
2.2.2 Class IIb two-peptide
Class IIb is a group of two-peptide bacteriocins, which optimal antimicrobial activity relies
on the presence of both peptides at about equimolar amounts (Nissen-Meyer et al. 2010).
The two peptides are normally named with consecutive two alphabetical letters, for
example plantaricin E/F from Lb. plantarum C11 (Moll et al. 1999) or with additional α
and β in the end of protein names, such as Wα and Wβ for enterocin W (Sawa et al. 2012).
All two-peptide bacteriocins identified so far contain consensus motifs in their aa
sequences, most commonly GxxxG (Nissen-Meyer et al. 2010), or similar AxxxA- and
SxxxS- motifs in plantaricin Sβ (Jiménez-Díaz et al. 1995) and plantaricin NC8β
(Maldonado et al. 2003), respectively. The genes encoding the two peptides are located
next to each other in the same operon near the abovementioned crucial genes (Anderssen
et al. 1998). Moreover, the production of some two-peptide bacteriocins is
transcriptionally regulated through a three-component regulatory system (Oppegård et al.
2007), which will be discussed later in the introduction chapter 2.2.5 Regulation
mechanism.
All two-peptide bacteriocins have been shown to render cell membranes leakage of
various small molecules, including a wide range of monovalent cations like Na+, K+, Li+,
Cs+, Rb+ etc., but not divalent cations (Oppegård et al. 2007). Plantaricins for example can
form pores in the membranes of target cells and dissipate the transmembrane electrical
potential and pH gradient (Moll et al. 1999). Circular dichroism studies of lactococcin G,
plantaricin EF and plantaricin JK have found out that all these peptides are unstructured
in aqueous face (Fimland et al. 2008; Rogne et al. 2008; Rogne et al. 2009). These results
indicated that these bacteriocins would start structuring upon the contact with membrane-
associated molecules.
A few targets for class IIb bacteriocin have been identified. By whole-genome sequencing,
Kjos et al. (2014) identified mutation in or near the gene uppP in lactococcin G-resistant
mutants. The undecaprenyl pyrophosphate phosphatase encoded by uppP is a membrane
protein involved in peptidoglycan synthesis. Overexpression of lactococcal UppP in
naturally resistant Streptococcus pneumoniae could convert the Streptococcus strain
17
sensitive to lactococcin G. The sensitivity to similar bacteriocins lactococcin Q (Zendo et
al. 2006) or enterocin 1071 (Kjos et al. 2014) is also dependent on the presence of UppP.
Lately, amino acid-polyamine-organocation (APC) transporters were suggested to be the
target of two-peptide bacteriocin plantaricin JK based on sequence comparison studies
(Oppegård et al. 2016). All identified two-peptide bacteriocins possess GxxxG-like motifs.
They mediate the bacteriocins to form penetrating helix-helix structure in the target cell
membrane (Nissen-Meyer et al. 2010; Oppegård et al. 2008). The recent structural study
on plantaricin EF indicated that the G5xxxG9 motif  in  PlnE  possibly  interacts  with  the
S26xxxG30 motif of PlnF in an antiparallel transmembrane orientation in a model lipid
bilayer (Ekblad et al. 2016).
Alignment of existing immunity proteins of two-peptide bacteriocins also revealed high
level of similarity (Oppegård et al. 2010). The function of immunity proteins is often
confirmed by heterologous expression the immunity gene in naturally sensitive cells
resulting in the cells resistant to corresponding bacteriocins. By cloning and expressing
putative class IIb lactococcin G immunity protein LagC significantly increased the
immunity in the host Lactococcus, suggesting the immunity function of LagC (Oppegård
et al. 2010).
2.2.3 Class IIc circular
A class IIc cyclic bacteriocin has the structure of a closed head-to-tail circle. In general,
the expression of circular bacteriocin structural genes must be combined with the activity
of proteins involved in maturation (cleavage/circularization) and secretion via different
transporter systems, as well as multifaceted immunity mechanisms to ensuring the cells’
self-protection against own bacteriocin (Maqueda et al. 2008). Circular bacteriocins are
expressed in the form of precursors with hugely variable N-terminal leader peptides
(Gabrielsen et al. 2014b). The leader peptides are cleaved off from the precursors.
Enterocin NKR-5-3B was found to be processed by proteins EnkB1234. These proteins
are responsible for the leader and core peptide recognition, maturation and secretion of the
circular bacteriocins (Perez et al. 2016).
Comparing with the other class II bacteriocins, class IIc bacteriocins have relatively
broader antimicrobial spectra (Himeno et al. 2015; Maqueda et al. 2004). All the circular
bacteriocins characterised so far from LAB, bacilli and clostridia are active against Gram+
bacteria of the phylum of Firmicutes (Acedo et al. 2015; Gabrielsen et al. 2014a; Perez et
al. 2016). Most circular bacteriocins share a common three-dimensional structure
including 4 or 5 α-helices and a hydrophilic core (Van Belkum et al. 2011). It is not clear
whether circular bacteriocins require receptor molecules on the sensitive cells for target
recognition. However, like other bacteriocins, circular bacteriocins permeabilize cell
membrane resulting ion leakage, dissipation of the membrane potential, and eventually
cell death (Gabrielsen et al. 2014a). Enterocin AS-48 (Gálvez et al. 1991), carnocyclin A
(Gong et al. 2009), gassericin A (Kawai et al. 2004) and subtilosin A (Thennarasu et al.
2005) could permeabilize the liposomes and/or lipid bilayers, indicating that direct
contacting to the target cell might be sufficient without any specific receptor. However, a
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maltose ABC transporter complex in Lc. lactis was  shown  to  be  directly  linked  to  the
sensitivity to garvicin ML, as large deletion of malEFG encoding maltose transporter and
its flanking region in chromosome was found in garvicin-resistant Lactococcus
(Gabrielsen et al. 2012).
The specific ABC transporter can also protect the cells from exogenously produced
bacteriocin. The transporter of cyclic bacteriocin enterocin AS-48 not only acts as a second
immunity mechanism but also enhances the immunity to its bacteriocin (Diaz et al. 2003).
DUF96 superfamily protein LcyD has also been shown to display immunity and secretion
duo-function for the production of leucocyclicin Q (Mu et al. 2014). The protection
mechanism is likely to be achieved by removing the bacteriocins from the cytoplasmic
membrane. Additionally, leucocyclicin Q producer strain Ln. mesenteroides TK41401 can
display cross-immunity against similar bacteriocin lactocyclicin Q, which is originally
produced by Lactococcus sp. QU12 (Masuda et al. 2011).
2.2.4 Class IId single, linear, non pediocin-like
Class IId represents various heterogeneous one-peptide, linear, non-pediocin like
bacteriocins according to the Cotter’s classification scheme (2013). However, the range
of this class covers broad and variable non-modified bacteriocins, comparing with the
other three subclasses, and thus has been evolving along with the recognition of  new
bacteriocins. Because of the diverse nature of class IId bacteriocins, these is no consensus
biosynthesis, mode of action, or immunity mechanism for all the members. According to
the secretion pattern, Iwatani et al. (2011) consider there are three types of class IId
bacteriocins: 1) sec-dependent bacteriocins; 2) leaderless bacteriocins; and 3) non-
subgrouped bacteriocins.
The best characterised example of this group is lactococcin A from Lc. lactis ssp. cremoris
LMG 2130. Like class IIa bacteriocins, lactococcin A is secreted through ABC transporter
and leaks the target cell membrane by targeting to Man-PTS (Diep et al. 2007; Holo et al.
1991). The immunity protein LciA of lactococcin A was shown to have different
conformation inside of the cells and to function differently with and without the presence
of the associated bacteriocin. When the lactococcin A is present, LciA could tightly
associate with the membrane located Man-PTS receptor and the bacteriocin (Diep et al.
2007).
Some class IId bacteriocins are synthesised without N-terminal leader sequence, that
makes the bacteriocin recognition and secretion mysterious (Alvarez-Sieiro et al. 2016).
For example, Lacticin Q is a leaderless bacteriocin from Lactococcus and has relatively
wide antimicrobial spectrum. The presence of genes encoding ABC transporter suggests
that the dedicated transporter possibly facilitates secretion and self-immunity of lacticin
Q (Iwatani et al. 2012). Yet this particular bacteriocin seems not to require any specific
docking molecule, but rather interact with the outer membrane to form “huge toroidal
pores” coupled with lipid flip-flop (Yoneyama et al. 2009). Lacticin Q killing mechanism,
however, is highly dependent on the physicochemical features of the outer membrane
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components,  i.e.  only  Gram+ bacteria would be possibly sensitive to the bacteriocin
(Yoneyama et al. 2011). Li et al. (2013) also suggested that the strain-dependent level of
hydroxyl radical accumulation by lacticin Q resulted in antimicrobial activity in specific
strains. On the other hand, LsbB, another leaderless bacteriocin, appears to require a
membrane-bound Zn-dependent metallopeptidase to bind to the target cell (Uzelac et al.
2013). In addition to being the common target molecule for class IIa bacteriocins, Man-
PTS also serves as the receptor for the class IId bacteriocin lactococcin A. But both IIC
and IID units from the same source are required to kill the target cells (Diep et al. 2007;
Kjos et al. 2010).
Lactococcin 972 from Lc. lactis IPLA972 contains a 25-aa sec-dependent signal peptide,
which is used in the sec-dependent pathway to secrete 66-aa mature bacteriocins without
dedicated transporters (Martıńez et al. 1999). Lactococcin 972 has been found to
specifically interact with the cell wall precursor lipid II and inhibit the cell wall
biosynthesis at the division septum. Furthermore, despite lipid II is a universal molecule
for prokaryotes, this bacteriocin can kill only certain species of the Lactococcus family,
suggesting other receptor might be needed to determine its specificity (Martínez et al.
2008). Similar activity against septum formation was also observed in transmission
microscopy image of garvicin A from Lc. garvieae 21881 against other Lc. garvieae
strains (Maldonado-Barragan et al. 2013).
2.2.5 Regulation mechanism
As briefly mentioned earlier, bacteriocin production can be tightly regulated. In some LAB,
the production of class II bacteriocins is regulated by a quorum sensing-based three-
component regulatory system (3CS) (Nes et al. 2007). The communication between cells
depends on an induction factor, i.e. peptide pheromone, in the environment. When
pheromone accumulates to a certain threshold concentration, the membrane-bound
histidine protein kinase, is activated and triggers a series of autophosphorylation reactions.
In the end, an intracellularly phosphorylated response regulator binds to the regulated
promoters to activate a set of genes (Figure 2 on page 20) (Nes and Eijsink 1999). In some
instances, regulation is accomplished by a two-component system. The extracellular
bacteriocin-like peptide functions as induction factor and is detected by the histidine
kinase. The cytoplasmically located response regulator then mediates the response (Cotter
et al. 2005).
The regulation system has been thoroughly studied with the synthesis of plantaricins in
Lb. plantarum C11 (Diep et al. 1996; Diep and Nes 1995). Diep et al. (2003) has shown
that the peptide pheromone plantaricin A induces the production of two-peptide
bacteriocins plantaricin J/K and plantaricin E/F in a highly-regulated manner and fine
timing. However, even though plantaricin A shared most physicochemical properties of
other class II bacteriocins, the peptide itself did not show significant bacteriocin activity
(Nes et al. 1996). Other examples which production is regulated by such system are class
IIa bacteriocins carnobacteriocin B2 (Quadri et al. 1997) and sakacin A (Ennahar et al.
2000). Recently, it has been suggested that the full expression of leaderless bacteriocin
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Figure 2. The production of class IIa bacteriocin: three-component regulatory system, biosynthesis, secretion, and immunity. CM, cell membrane. Im, immunity protein. Man-PTS,
mannose phosphotransferase system, bacteriocin receptor IIC and IID. Adapted from Ennahar et al. (2000).
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LsbB is regulated by a transcription terminator sequence located downstream of the
structural gene (Uzelac et al. 2015). Moreover, the production of two-peptide bacteriocin
plantaricin NC8 was induced only by co-culturing the producer Lb. plantarum NC8 with
Lc. lactis MG1363 or Pediococcus pentosaceus FBB63 (Maldonado et al. 2003).
In addition, environmental factors also affect the bacteriocin biosynthesis, such as
temperature, ionic strength and pH, etc. Most bacteriocinogenic bacteria tend to produce
more bacteriocins at around 25 °C with slight acidic environment (Mataragas et al. 2003;
Zhou et al. 2015). Many are reported to stop bacteriocin production at high temperature
(above 35 °C). However, P. acidilactici manages to produce pediocin even at 45 °C
(Turgis et al. 2016). Innate quorum sensing regulatory mechanism can be suppressed by
environmental temperature. The production of sakacin A is regulated by 3CS at 25 - 30 °C,
yet significantly reduced at higher temperature (33.5 - 35 °C) (Diep et al. 2000).
2.2.6 Bacteriocin spontaneous resistance
Resistance to bacteriocins may compromise their use as biopreservatives in food or as
anti-infection agents. On the other hand, bacteriocin resistance inspires researchers to
identify the bacteriocin target molecules thus understanding bacteriocins’ mode of action.
For some class II bacteriocins, sensitive cells can develop resistance when exposed to
bacteriocin. The frequency of resistance development varies depending on the bacteriocin
and also the sensitive strains. L. monocytogenes can develop resistance to class IIa
bacteriocins, with resistance frequency up to 10-4 (Gravesen et al. 2002b). As the targeting
mechanism for class IIa bacteriocins has been well studied, their resistance mechanisms
are investigated in detail. As more bacteriocin targets are identified, the view of how
bacteria develop resistance to bacteriocins become clearer gradually.
For class IIa bacteriocins and class IId lactococcin A, the MptC and MptD of Man-PTS is
responsible for bacteriocin targeting (Kjos et al. 2011a; Opsata et al. 2010). Down-
regulation of Man-PTS expression not only leads to the reduction in cell  growth on
glucose, but also results in bacteriocin resistance in L. monocytogenes, En. faecalis and
Lc. lactis (Gravesen et al. 2002b; Kjos et al. 2011b; Opsata et al. 2010; Tessema et al.
2009). Since the expression of Man-PTS in L. monocytogenes is regulated through several
proteins (Vu-Khac and Miller 2009), it is possible that any mutation at these areas in the
genome would interfere the Man-PTS expression and thus may cause the resistance.
In case of two-peptides, the sensitive Weissella viridescens developed stable mutation,
resistant to the plantaricin JK upon bacteriocin challenge. Mutations were identified at
genomic positions encoding the putative target of two-peptide bacteriocins, APC family
transporter (Oppegård et al. 2016). As for lactococcin G, mutation in the bacteriocin target
molecule UppP was shown to lead to the bacteriocin resistance (Kjos et al. 2014). The
occurrence of resistance to class IId lactococcin 972 is linked to upregulation of llmg2447
which encodes a putative extracytoplasmic function anti-sigma factor (Roces et al. 2012).
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2.3 Leuconostoc bacteriocins
Bacteriocins produced by Leuconostoc species are often called leucocins. Some are named
mesentericins, as they are produced by Ln. mesenteroides strains. There are at least 40
Leuconostoc bacteriocins identified so far (Table 3 on page 23-24).
Although many Leuconostoc bacteriocins have been well characterised, nomenclature of
these peptides seems confusing. As one of the most studied leucocins, leucocin A has
several different names, most of which indicate the producer, but some created quite a
confusion. For example, leucocin B Ta11a from Ln. carnosum Ta11a (Felix et al. 1994)
and leucocin C LA7a from Ln. paramesenteroides La7a (Hastings et al. 1996) have
identical aa sequence to leucocin A. The only differences between several leucocin As are
found in the leader peptides (Table 3). As the producer strains are different for the
leucocinAs, it might explain why the leader peptides vary. Considering all the different
names for literally same compounds, it seems logical to use unified nomenclature in the
future studies of leucocins.
Bacteriocins produced by Ln. mesenteroides species are confusingly given two names
mesentericin or mesenterocin, among which mesenterocin 52A (Revol-Junelles et al. 1996)
and mesenterocin E131 (Xiraphi et al. 2008) are identical to mesentericin Y105 (Héchard
et al. 1992). Some Leuconostoc bacteriocins are not given specific names, although their
biologic features have been well studied (Mataragas et al. 2003). In terms of the aa
sequence of bacteriocin core peptide, mesentericin/mesenterocin differs from leucocin A
by only two aa. Meanwhile, not all the leucocin Cs identified so far shared exactly same
sequence (Table 3).
Because of taxonomic changes, some previous Leuconostoc species are now included in
the genus of Weissella, therefore the nomenclature of the corresponding bacteriocins are
derived from the name of Weissella. For example, weissellin A produced by Weissella
paramesenteroides (Papagianni and Papamichael 2011) is a class IIa bacteriocin and
shares 73 % similarity with leucocin C. This particular Weissella paramesenteroides was
firstly described as Ln. paramesenteroides (Garvie 1967), and later emended to Weissella
genus (Collins et al. 1993; Padonou et al. 2010).
In the 1990’s, the studies of Leuconostoc bacteriocins were mostly about the discovery of
the compounds, their antimicrobial spectrum and the confirmation of bacteriocin nature
(Daba et al. 1991; Janes et al. 1999). From later 1990’s to the 2000’s, more researchers
started to reveal the bacteriocin sequences (Budde et al. 2003; Fimland et al. 2002b; Revol-
Junelles et al. 1996). As time went on to the 2010’s, the trend of bacteriocin studies went
deeper to their mode of actions, and discovery through genome mining technique
(Alvarez-Sieiro et al. 2016; Kjos et al. 2011a).
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Table 3. Bacteriocins produced by Leuconostoc species.
Name Producer Description, sequence, antimicrobial spectrum Reference
Leucocin A ........................|.........10........20........30........40....
leucocin A-UAL 187 Ln. gelidum UAL 187  MMNMKPTESYEQLDNSALEQVVGGKYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW- Hastings et al. (1991)
leucocin 6A Ln. mesenteroides 6 CFS  ........................KYYGNGVHCTKxGCSVNWGEAFSAGVHRLANGGNGFW- Vaughan et al. (2001)
leucocin A TA33a Ln. mesenteroides TA33a  ........................KYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW- Papathanasopoulos et al. (1998)
leucocin A-QU 15 Ln. pseudomesenteroides QU 15  MNNMKSADNYQQLDNNALEQVVGGKYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW- Sawa et al. (2010)
leucocin A (∆7) Ln. pseudomesenteroides QU 15  ........................KYYGNGVHCTKSGCSVNWGEAFSAGVHRLA- Sawa et al. (2010)
leucocin A Ln. carnosum 4010  MNNMKSADNYQQLDNNALEQVVGGKYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW- Wan et al. (2013)
leucocin A-4010 Ln. carnosum 4010  ........................KYYGNGVHCTKSGCSVNWGEAFSAGVHRLA....... Budde et al. (2003)
leucocin B TA11a Ln. carnosum TA11a  MNNMKSADNYQQLDNNALEQVVGGKYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW- Felix et al. (1994)
leucocin B-KM432Bz Ln. pseudomesenteroides KM432Bz  MNNMKSADNYQQLDNNALEQVVGGKYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW- Makhloufi et al. (2013)
leucocin C-LA7a Ln. paramesenteroides LA7a  MNNMKSADNYQQLDNNALEQVVGGKYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW- Hastings et al. (1996)
Leucocin B ........................|.........10........20........30........40....
leucocin B TA33a Ln. mesenteroides TA33a   .......................KGKGFWSWASKATSWLTGPQQPGSPLLKKHR- Papathanasopoulos et al. (1998)
leucocin B Ln. carnosum 4010   MLNKDMRDFKQLSDNDLQAISGGKGKGFWSWASKATSWLTGPQQPGSPLLKKHR- Wan et al. (2015)
Leucocin C ........................|.........10........20........30........40....
leucocin B-4010 Ln. carnosum 4010  ........................KNYGNGVHCTKKGCSVDWGYAWTNIANNSVMNGLTGGNA.... Budde et al. (2003)
leucocin C Ln. mesenteroides 6 . .......................KNYGNGVHCTKKGCSVDWGYAWTNIANNSVMNGLTGGNAGWHN- Fimland et al. (2002b)
leucocin C Ln. carnosum 4010  MMNMKPTESYEQLDNSALEQVIGGKNYGNGVHCTKKGCSVDWGYAWTNIANNSVMNGLTGGNAGWHN- Wan et al. (2013)
leucocin 6C Ln. mesenteroides 6 CFS  ........................KNYGNGVHCTKKGCSVDWGYAATNIANNSVMNGLT........ Vaughan et al. (2001)
leucocin 7C Ln. mesenteroides 7 CFS  ........................KNYGNGVHCTKKGCSVDWGYAWTNIANNSV............. Vaughan et al. (2001)
leucocin 10C Ln. mesenteroides 10 CFS  ........................KNYGNGVHCTKKGCSVDWGYAWTNIANNSVMNGLT........ Vaughan et al. (2001)
leucocin C TA33a Ln. mesenteroides TA33a  ........................KNYGNGVHCTKKGCSVDWGYAATNIANNSVMNGLTG....... Papathanasopoulos et al. (1998)
Other leucocins ........................|.........10........20........30........40....
leucocin Q Ln. pseudomesenteroides QU 15    MKNQLMSFEVISEKELSTVQGGKGLGKLIGIDWLLGQAKDAVKQYKKDYKRWH- Sawa et al. (2010)
leucocin N Ln. pseudomesenteroides QU 15 MNKEYNSISNFKKITNKDLQNINGGFIGRAIGDFVYFGAKGLRESGKLLNYYYKHKH- Sawa et al. (2010)
leucocin F10 Ln. carnosum F10 antilisteria Parente et al. (1998)
leucocin H Ln. MF215B two-peptide Blom et al. (1999)
leucocin OZ Ln. carnosum OZ antilisteria Osmanağaoğlu (2007)
leucocin K Ln. sp. LAB145-3A against Enterococcus and Listeria Choi and Ahn (1997)
leucocin K7 Ln. mesenteroides K7 antilisteria Shi et al. (2016)
leucocin BC2 Ln. mesenteroides BC2 against Listeria, Enterococcus, Bacillus Janes et al. (1999)
Leuconostoc bacteriocins not named as leucocin ........................|.........10........20........30........40....
mesentericin Y105 Ln. mesenteroides Y105  MTNMKSVEAYQQLDNQNLKKVVGGKYYGNGVHCTKSGCSVNWGEAASAGIHRLANGGNGFW- Héchard et al. (1992)
mesentericin Y 10537 Ln. mesenteroides Y105                          KYYGNGVHCTKSGCSVNWGEAASAGIHRLANGGNGFW- Fleury et al. (1996)
mesenterocin E131 Ln. mesenteroides E131  ........................KYYGNGVHCTKSGCSVNWGEAASAGIHRLANGGNGFW- Xiraphi et al. (2008)
mesenterocin 52A Ln. mesenteroides ssp.
mesenteroides FR52
 ........................KYYGNGVHCTKSGCSVNWGEAASAGIHRLANGGNGFW- Revol-Junelles et al. (1996)
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mesenterocin 52B Ln. mesenteroides ssp.
mesenteroides FR52
 ........................KGVLGWLSMASSALTGPQQPNSPWLAKIKNHK- Revol-Junelles et al. (1996)
mesentericin ST 99 Ln. mesenteroides ssp. dextranicum ST99 Todorov and Dicks (2004)
mesenterocin 5 Ln. mesenteroides UL5 antilisteria Daba et al. (1991)
mesenterocin Y Ln. mesenteroides E131 against Enterococcus, Listeria, Pseudomonas, and Salmonella species Zdolec et al. (2008)
mesenterocin Ln. mesenteroides OZ antilisteria Osmanağaoğlu and Kiran (2011)
carnocin 54 Ln. carnosum LA54A amylase-sensitive, against Leuconostoc, Carnobacterium, Enterococcus
and Listeria species
Keppler et al. (1994)
dextranicin 24* Ln. mesenteroides ssp. dextranicum J24                          KGVLGWLSMASSALTGPQQ.................. Revol-Junelles and Lefebvre
(1996)
kimchicin GJ7 Ln. citreum GJ7 enhanced bacteriocin production by growing with inducing factor from Lb.
plantarum
Chang et al. (2007)
leuconocin J Ln. sp. J2 against S. aureus Choi et al. (1999)
leuconocin S Ln. paramesentroides OX amylase-sensitive, against Lb. sake Lewus et al. (1992)
leucocyclicin Q** Ln.
mesenteroides
TK41401
MFLVNQLGISKSLANTILGAIAVGNLASWLLALVPGPGWATKAALATAETIVKHEGKAAAIAW- Masuda et al. (2011)
* N-terminal sequence identical to mesentericin B105; ** cyclic bacteriocin; | cleavage site between the leader and core peptides; - indicates the sequence is
complete; ... indicates incomplete sequences; x indicates unidentified amino acid; black shading, non-identical amino acids between leucocin As and
mesentericins/mesenterocins; colour shading, non-identical amino acids between leucocin Cs.
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3 Heterologous expression of class II bacteriocins from LAB
In many instances, the target bacteriocin we would like to study is produced by a bacterium
which is difficult to handle, or at inconveniently low concentration, or co-produced with
other active compounds in the native host. Heterologous expression thus enables the
production of a certain peptide in an easier host and at higher yield, that facilitate the
downstream researches and applications.
So far quite many class II bacteriocins have been overexpressed in heterologous hosts,
either closely related, such as Lactococcus, or common engineer hosts like E. coli or yeast
with the intention to increase bacteriocin yield. Leuconostoc bacteriocin leucocin C was
produced under the control of P45 promoter in E. coli, and heterologous leucocin C also
displayed antimicrobial activity against L. monocytogenes (Liu et al. 2013). A few yeast
expression platforms have also been developed to produce heterologous peptides and
proteins, including LAB bacteriocins such as enterocin A and bacteriocin E50-52 in Pichia
pastoris and Kluyveromyces lactis (Borrero et al. 2012; Jiménez et al. 2014).
3.1 Expression of native bacteriocin genes
In the early studies of bacteriocins, genes required for the production of AMPs were
conventionally cloned as a bundle in the heterologous hosts. The production of class IIa
model bacteriocin pediocin requires the ped operon of four genes from P. acidilactici
PAC1.0. Marugg et al. (1992) cloned all pedABCD in E. coli and the resultant
heterologous pediocin showed activity against L. monocytogenes. Moreover, the whole
operon about 1.2 kb encoding both of the two-peptides of lactacin F and the putative
immunity protein from Lb. johnsonii was cloned and expressed in Carnobacterium species
which is also the producer for carnobacteriocins (Allison et al. 1995). The native
processing and exporting mechanism in Carnobacterium was shown to successfully
produce bioactive lactacin F.
3.2 Optimisation of bacteriocin production
Most LAB bacteriocins require a dedicated processing and secretion system, i.e. ABC
transporter and accessory proteins (Ennahar et al. 2000). The secretory mechanism can
recognise bacteriocin’s leader peptide, which can vary dramatically among different
species and strains. To optimise the production in the other host, LAB bacteriocin’s mature
part can be fused with leader sequence which is recognised better in the host strain.
Stronger promoters can be used to make the host produce heterologous peptides more.
Inducible promoter such as PnisA was used to produce pediocin at higher yield with
negligible amount of nisin for induction. However, the optimal potency requires the
accessory protein PedC (Back et al. 2016). Recently, a few strong constitutive promoters
were identified from Lc. lactis, and nisin Z production could be doubled by using the
newly discovered P8 promoter instead of conventional P45 (Zhu et al. 2015a).
Additionally, Zhu et al. (2017) have found out that deleting non-essential genomic regions
by only 2.83 % from Lc. lactis NZ9000 made the strain not only grow fast in both rich
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media and chemically defined media, but also produce 2.5-fold more leucocin C.
Bacteriocins have also been fused to an extra protein/peptide and co-expressed as one
fusion protein in heterologous host. The protein extension, such as His-tag for plantaricin
NC8 (Jiang et al. 2016) or thioredoxin plantaricin Pln1 (Meng et al. 2016), facilitates the
purification procedure and is cut off by protease leaving bioactive bacteriocins.
Furthermore, Enterocin E50-52 and pediocin hybrid bacteriocins have shown improved
antimicrobial activities against Micrococcus luteus, Salmonella enterica, E. coli O157:H7
(Tiwari et al. 2015).
4 LAB bacteriocin applications
LAB have been associated with food fermentations for at least 4000 years. At the moment,
when one searches “bacteriocin” and “application” as keywords, the majority of the
researches focuses on using bacteriocins as bio-preservatives in food industry.
As LAB bacteriocins have strong antibacterial activity, being produced by harmless LAB
and have not been shown to have any toxic effect on mammalian cells, they seem to be
ideal for killing harmful and pathogenic bacteria in food and feed. Bacteriocins can be
used in food as part of hurdle technology to prolong shelf life and improve food quality.
For example, cider can be spoiled by the growth of exopolysaccharide producing bacteria,
e.g. Bacillus licheniformis, forming slime and giving the drink a “ropy” appearance
(Larpin et al. 2002). Enterocin AS-48 produced by En. faecalis A-48-32 has been found
to make B. licheniformis more liable to heat-treatment, thus combining bacteriocin with
heat-treatment would be more efficient to inactivate spore forming Bacillus in cider
(Grande et al. 2006). The growth of L. monocytogenes is a major concern in dairy industry.
Partially purified leucocin K7 from Ln. mesenteroides K7  was  shown  to  inhibit L.
monocytogenes in milk (Shi et al. 2016). Additionally, bacteriocin producing starter
cultures have been found useful in preventing food spoilage and killing pathogenic
bacteria in food (De Vuyst and Leroy 2007). Bacteriocin-containing freeze-dried LAB
powder has been found to inhibit Listeria in hot dogs, simply by applying the powder onto
the surface of the hot dogs (Ünlü et al. 2016).
In addition to being used directly, bacteriocins can also be incorporated to packaging films
which are then used in food wrapping. Packaging films coated with solution containing
nisin could inhibit the growth of L. monocytogenes on the surface of packed hot dogs
(Franklin et al. 2004) and M. luteus spiked in milk (Mauriello et al. 2005). Ercolini et al.
(2006) used bacteriocin 32Y from Lb. curvatus to coat regular polythene film, which in
turn could reduce the superficial contaminant Listeria on the surface of food products
packed in the film. Although the bacteriocin applications in food have been shown very
successful in pilot studies, so far among hundreds of bacteriocins, nisin is the only
commercial bacteriocin approved for application in e.g. certain cheese, cream and pudding
products (EFSA 2006); ready-to-eat meat and poultry products, and finished sausage
(FDA 2001).
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MRSA and vancomycin-resistant enterococci have caused increasing number of infections
harder to treat and become major medical problems in hospitals around the world. Okuda
et al. (2013) reported that nisin A was especially effective against antibiotic-resistant
staphylococci, followed by lacticin Q from Lc. lactis strains. As many staphylococci form
biofilms which increase their resistance to chemotherapies making infections more
difficult to treat. In vitro, combining nisin with other conventional antibiotics such as
chloramphenicol, vancomycin or ciprofloxacin displayed enhanced inhibitory effects
toward MRSA (Dosler and Gerceker 2012; Field et al. 2016). Geldart (2016) presented
their results in the international antimicrobial peptide symposium in France, that a
engineered Lc. lactis  producing enterocin A, enterocin P and hiracin JM79 could
significantly reduce the pathogenic vancomycin-resistant enterococci counts in murine
model, and by combining these bacteriocins with traditional antibiotics may revive the
activity against Enterococcus. Additionally, various bacteriocins have been reported to
kill viruses. For example, enterocin CRL35 from En. faecium and subtilosin from Bacillus
amyloliquefaciens display inhibitory activity towards human herpesvirus. These
bacteriocins disturb the fusion of the viral envelope with the cellular membrane, therefore
inhibit the viral replicative cycle (Quintana et al. 2014; Wachsman et al. 1999).
5 LAB genome editing
Conventionally lactic acid bacterial genome editing has been accomplished through
homologous recombination using an integration vector that carries two chromosomal
fragments (H1 and H2) flanking the area X to be deleted. This approach involves two
crossover steps: 1) a plasmid carrying two adjacent chromosomal fragments H1H2
integrates into the target strain’s chromosome at either of the two homologous regions
through single crossover (SCO). Selection of integrants typically relies on antibiotic
resistance. 2) without antibiotic selection pressure, a second recombination occurs and the
unnecessary plasmid is removed from bacterial chromosome. As a result, double crossover
(DCO) cells have either deleted the target region X, or reversed to the wild-type genotype.
The frequency of recombination is approximately 10-4 (Gravesen et al.  2002a) and only
part of the DCO colonies carry the deletion, thus finding the desired strain without
selection often requires extensive screening. So far, a few systems have been developed
to increase DCO frequency or select the colonies in which DCO has happened.
Thermosensitive (TS) pG+Host vectors have been used to knock out chromosomal areas
from Lc. lactis genome (Biswas et al. 1993). The TS vector is sensitive to temperature and
only replicates at 28 °C. This feature facilitates the Lc. lactis to uptake the vector with
high frequency and allow the vector to replicate at 28 °C. Once the temperature rises to
37 °C, vector stops replicating and can integrate into the chromosome through
homologous recombination as designed. By shifting the temperature back to 28 °C,
integrated plasmid starts to replicate and is removed from the chromosome through second
recombination, resulting either deletion or wild-type reversion.
Another recombination system used in Lc. lactis is based on Cre-lox (Zhu et al. 2015b),
which was originally used in multiple gene deletions Lb. plantarum (Lambert et al. 2007).
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After SCO, integrant is first selected with erythromycin and chloramphenicol. Then part
of the integrated vector including the erythromycin resistance gene is lost through DCO.
As a result, the target region X is replaced by the chloramphenicol resistance gene cat
flanked by lox recognition sites for the Cre recombinase. Finally, the lox-cat-lox cassette
is removed via transient expression of the Cre recombinase, leaving short inactive lox-
sites into the chromosome (Lambert et al. 2007). In this method, there is no actual selection,
and the second crossover was still found by screening for the erythromycin sensitivity.
Moreover, the Cre-lox-based gene deletion is not completely clean, as the lox-sites remain
after the procedure.
In order to select the DCO colonies, a few systems incorporated with negative selection
markers have been developed. The integration of the vector is selected with the positive
marker (usually antibiotic resistance gene), whereas the loss of the plasmid is selected
with the negative marker which causes the sensitivity towards certain selective agent.
Viable strains will be the ones which have excised the negative marker through second
homologous recombination. For Lc. lactis, a counterselectable vector based on 5’-
fluoroorotic acid (FOA) sensitivity has been developed (Solem et al. 2008). The
integration introduces the orotate transporter gene oroP, which makes the cells sensitive
to FOA. Yet, Lc. lactis has to be cultured in chemically defined media supplemented with
FOA to make DCO colonies selectable. Moreover, as oroP is commonly present in Lc.
lactis strains (Siezen et al. 2011), unwanted homologous recombinations between the
native and the introduced oroP genes may occur during the process. In Lb. acidophilus,
Lb. casei, and Lc. lactis, a uracil phosphoribosyltransferase (upp) based counterselection
method has been developed (Goh et al. 2009; Song et al. 2014). Similarly, expression of
upp from integration vector causes sensitivity to 5-fluorouracil, which can be used to select
the DCO colonies.
Interestingly, although the method using clustered regularly interspaced short palindromic
repeats (CRISPR) and the associated DNA endonuclease Cas has gained most attention
recently, the system has not yet been used in editing lactococcal genomes. CRIPSR/Cas
system was adapted and combined with the idea of recombination to select the desired
gene deletion in Gram+ Clostridium berjerinckii (Wang et al. 2015). In terms of LAB,
CRISPR/Cas was used to aid the screening of short gene replacement in Lb. reuteri
genome (Oh and van Pijkeren 2014).
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AIMS OF THE STUDY
The main objectives of this doctoral study were to characterise the genetics of bacteriocins
produced by Leuconostoc carnosum 4010 (I, II), and to exploit the class IIa bacteriocin
targeting mechanism in Lc. lactis genome editing (III). The detailed aims of the research
were to:
1. study the genetics required for the production of leucocins B and C in Ln. carnosum
4010, and overexpress these leucocins in food-grade lactic acid bacteria Lc. lactis.
2. investigate the functions of the proteins related to leucocin production in the strain 4010.
3. utilise the class IIa bacteriocin targeting mechanism and develop a counterselection
system for seamless gene deletions for Lc. lactis.
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MATERIALS AND METHODS
Bacterial strains and plasmids used in this study are listed in Table 4 and Table 5 (on page
31), respectively. Experimental methods are summarised in Table 6 (on page 32) and
explicated in the articles I, II, and III present at the end of this book.
Table 4. Bacterial strains used in this study.
Bacterial strains Relevant properties Reference/source Used in
Leuconostoc carnosum
4010
Wild-type leucocin
producer,  DMRICC 4010a
Chr. Hansen A/S,
Hørsholm, Denmark;
Budde et al. (2003)
I, II
Ln. mesenteroides
ATCC 8293
Leucocin C-sensitive
indicator strain
ATCC I
Ln.
pseudomesenteroides
CIP103316
Indicator strain sensitive to
leucocins A, B, and C
A gift from Prof. Anne-
Marie Revol-Junelles,
University of Lorraine,
Nancy, France
II
Ln.
pseudomesenteroides
ACR
Spontaneous mutant of
CIP103316, resistant to
leucocins A and C
This study II
Weissella
paramesenteroides
LMA 19
Indicator strain sensitive to
leucocins A, B, and C
A gift from Prof. Anne-
Marie Revol-Junelles,
University of Lorraine,
Nancy, France
II
Lactobacillus
rhamnosus 1/6
Wild type strain, pepR
promoter
Valio Ltd., Helsinki,
Finland; Varmanen et al.
(1998)
I
Lb. plantarum WHE
92
Wild type pediocin producer Ennahar et al. (1996) III
Lactococcus lactis
MG1614
Transformation host Gasson (1983) II
Lc. lactis MG1363 Transformation host Gasson (1983) I
Lc. lactis N8 Wild type nisin producer,
target for chromosomal
deletions
Valio Ltd. Helsinki,
Finland
III
Lc. lactis NZ9000 Transformation host for
nisin-induced gene
expression, nisK and nisR
integrated into the
chromosome
Kuipers et al. (1998) I, II
Lc. lactis LAC358 NZ9000 carrying expression
vector pLEB688
Li et al. (2011) I
Lc. lactis LAC360 NZ9000 carrying the
secretion vector pLEB690
Li et al. (2011) I, II, III
Lc. lactis LAC404 MG1614 carrying lebB-
plasmid pLEB727
This study II
Lc. lactis LAC405 MG1363 carrying lecC-
plasmid pLEB728
This study I
Lc. lactis LAC406 MG1363 carrying lecCI-
plasmid pLEB729
This study I
Lc. lactis LAC407 MG1363 carrying lecI-
plasmid pLEB730
This study I
Lc. lactis LAC408 NZ9000 carrying lecCI-
plasmid pLEB729
This study I
Lc. lactis LAC409 NZ9000 carrying lecC-
plasmid pLEB728
This study I, II, III
Lc. lactis LAC410 NZ9000 carrying lebB-
plasmid pLEB727
This study II
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Lc. lactis LAC411 MG1363 carrying vector
pLEB690
This study I
Lc. lactis LAC420 MG1614 carrying lcnA-
plasmid pLEB756
This study II
Lc. lactis LAC428 NZ9000 carrying lcnA-
plasmid pLEB756
This study II, III
Lc. lactis MINL18 N8 carrying replicative mptC
expression plasmid
pWUST25
This study III
Lc. lactis MINL20 N8 carrying integrated
plasmid pWUST27
This study III
Lc. lactis MINL21 N8 carrying integrated
plasmid pWUST28
This study III
Lc. lactis MINL25 N8 with 22-kb deletion in
nisin-sucrose transposon
Tn5481
This study III
Lc. lactis MINL26 N8 with 33-kb deletion
including xyl operon
This study III
Lc. lactis MINL27 MINL25 carrying integrated
plasmid pWUST28
This study III
Lc. lactis MINL28 N8 with 22-kb deletion in
Tn5481, and 33-kb deletion
including xyl operon
This study III
Escherichia coli TG1 Transformation host Sambrook and Russell
(2001)
I, III
E. coli ECO757 TG1 carrying lecC-plasmid
pLEB731
This study Liu et al.
(2013)
E. coli ECO758 TG1 carrying lecI-plasmid
pLEB732
This study I
E. coli EMIN18 TG1 carrying replicative
mptC plasmid pWUST25
This study III
E. coli EMIN20 TG1 carrying integration
vector pWUST27
This study III
E. coli EMIN21 TG1 carrying integration
vector pWUST28
This study III
E. coli SAA594 TG1 carrying vector pTF1 This study I
Listeria monocytogenes
WSLC 1018
Indicator strain sensitive to
leucocins A and C, ATCC
19118
Prof. Martin Loessner,
ETH Zürich, Switzerland
I, II
L. monocytogenes
WSLC 1033
ATCC 19117, Source of
mptC gene
Prof. Martin Loessner,
ETH Zürich, Switzerland
III
L. monocytogenes
Scott A
Leucocin C-sensitive
indicator strain, NRRL B-
33013
Prof. Martin Loessner,
ETH Zürich, Switzerland
I
L. monocytogenes
MUU22
WSLC 1018 carrying vector
pTF1
This study I
L. monocytogenes
MUU23
WSLC 1018 carrying lecI-
plasmid pLEB732
This study I
Micrococcus luteus
ATCC10240
Indicator strain sensitive to
nisin
Valio Ltd., Helsinki,
Finland
this study
Table 5. Plasmid used in this study.
Plasmids Relevant properties Reference/source Used in
pLEB579 Lc. lactis cloning vector containing pSH71
repAC and ermC, ErmR
Beasley et al. (2004) III
pLEB688 Lc. lactis expression vector harbouring
lactococcal promoter P45. 3466 bp, NisR
Li et al. (2011) I
pLEB690 Lc. lactis secretion vector harbouring
lactococcal promoters P45 and PnisZ, and
signal sequence SSusp45. 3746 bp, NisR
Li et al. (2011) I, II
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pLEB727 Leucocin B gene lebB fused to SSusp45 in
pLEB690 (NaeI)
This study II
pLEB728 Leucocin C gene lecC fused to SSusp45 in
pLEB690 (NaeI)
This study I, II
pLEB729 Leucocin C and the immunity gene lecCI
fused to SSusp45 in pLEB690 (NaeI)
This study I
pLEB730 Leucocin C immunity gene lecI in pLEB688
(NcoI/SmaI)
This study I
pLEB731 lecC fused with SSusp45 and promoter P45
in pTF1 (EcoRI/SmaI)
This study Liu et al.
(2013)
pLEB732 lecI with pepR promoter from Lb.
rhamnosus 1/6 in pTF1 (EcoRI/SmaI)
This study I
pLEB756 Leucocin A gene lcnA fused to SSusp45 in
pLEB690 (NaeI)
This study II
pTF1 Gram−/Gram+ shuttle vector, 3043 bp, ErmR;
pLEB579 carrying multiple cloning site
from pBluescript
Gift from Dr. Lars
Fieseler, ETH Zürich,
Switzerland. pLEB579,
Beasley et al. (2004)
I
pWUST25 pLEB579 carrying nisin inducible promoter
PnisZ from Lc. lactis N8, mptC from L.
monocytogenes WSLC 1033, ErmR
This study III
pWUST27 Integration vector for Lc. lactis with pUC
ori, ermC, PnisZ-mptC, and two ~1-kb
fragments for 22-kb chromosomal deletion
from Lc. lactis N8
This study III
pWUST28 Integration vector for Lc. lactis with pUC
ori, ermC, PnisZ-mptC, and two ~1-kb
fragments for 33-kb chromosomal deletion
from Lc. lactis N8
This study III
Table 6. Methods used in this study.
Method Reference/source Used in
Basic DNA techniques, incl. PCR,
enzymatic modifications,
electrophoresis
Sambrook et al. (1989); Catalogues of
enzyme suppliers
I, II, III
Inverse PCR Ochman et al. (1988) I
Overlapping PCR Higuchi (1990) III
Two-step RT-PCR Freeman et al. (1999) II
Electroporation
E. coli Zabarovsky and Winberg (1990) I, III
Lc. lactis Holo and Nes (1989) I, II, III
L. monocytogenes Park and Stewart (1990) I
DNA isolation
E. coli GeneJET Plasmid Miniprep Kit, Thermo
Fischer Scientific
I, II, III
Lc. lactis II
L. monocytogenes I
Ln.. carnosum Anderson and McKay (1983) I
In vitro antimicrobial activity assay Harris et al. (1989) I, II, III
Southern blotting Ausubel et al 1987 I
SDS-PAGE and gel overlay Schägger and Von Jagow (1987) I, II
MIC determination This study II, III
Bacteriocin ammonium sulfate
precipitation
Green and Hughes (1955) I, II, III
Protein concentration with resin Agilent Genomics I
RNA purification and RT-PCR GeneJET RNA Purification Kit, Thermo
Fisher Scientific
II
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RESULTS AND DISCUSSION
1 Genetic characterisation of leucocins (I, II, unpublished)
By only knowing the aa sequences of mature leucocin C (Budde et al. 2003; Fimland et
al. 2002b), primers were designed to amplify lecC gene from Ln. carnosum 4010 based
on codon usage. lecC gene was amplified and sequenced. Primers to amplify leucocin A
gene were designed according to the published DNA sequence. The plasmid DNA was
isolated from the strain 4010, according to Anderson and Mckay’s method (1983) for
isolating large plasmids from Lactococcus with proper modifications (I). Southern blots
hybridised with digoxigenin-labelled leucocins A and C probes revealed that, like most of
other class IIa bacteriocins (Ennahar et al. 2000), leucocins A and C genes were found on
two large plasmids pLC-1 and pLC-2.
Ln. carnosum 4010 plasmids were digested with several enzymes. The restricted
fragments were self-ligated forming circular templates for the following inverse PCR.
Primers in the inverse PCR direct away from the core region of the known sequence, and
amplify the unknown areas up- and downstream of the known sequence in the circular
template. Sequence analysis of the amplified inverse PCR fragment showed that the 8-kb
AclI restriction fragment contains not only the genetic determinants for leucocin C, its
immunity protein and ABC transporter, but also 165-bp lebB and 486-bp lebI encoding a
class IId bacteriocin leucocin B and its immunity protein, respectively (II, Figure 3).
Figure 3. Gene clusters leucocins A, B, and C located in native plasmids of Ln. carnosum 4010.
Promoters are shown as black flags. Transcriptional terminators are shown as lollipop symbols. hyp,
hypothetical gene; mob, plasmid mobilisation gene; str, gene encoding stress induced DNA binding
protein; rep-ass, replication assistant gene; repB, plasmid replication gene; E’, truncated accessory
gene lcaE; tra8, transposase gene. Dark red, bacteriocin genes; red, immunity genes; X, accessory
gene lecX; T, translocator gene lecT; S secretion gene lecS.
Through several inverse PCR and sequencing approaches, leucocin C was found to be
encoded as a precursor by 204-bp lecC gene. The precursor possesses a GG-type leader
peptide with 24 aa in length, which is typical for many class IIa bacteriocins. A 294-bp
lecI encoding immunity protein share 48 % identity and 73 % similarity with immunity
protein of other class IIa bacteriocins, listeriocin and sakacin P. Next to the lecCI operon,
another operon with opposite direction contains 450-bp lecX encoding an accessory
protein for ABC-transporter, 2169-bp lecT and 1374-bp lecS needed for the ABC
transporter (I). Immediately after the lecXTS operon was a possible accessory gene yaiI
and then the operon of lebBI. Leucocin B precursor also contains a GG-type leader, which
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could be recognised by ABC transporter when crossing the cytoplasmic membrane (II).
The signal peptide of leucocin A in the strain 4010 was identical to that of leucocin A in
Ln. carnosum Ta11a, but different from leucocin A leader in Ln. gelidum UAL-187 by 7
aa (Felix et al. 1994). Despite the significant differences between leucocin and
mesentericin sequences, the organisation of leucocin operons (lecICXTS, yaiI and lebBI)
in Ln. carnosum 4010 resembles the mesentericins Y and B operons (mesIYCDEFHB(G))
from Ln. mesenteroides FR52 and Y105, respectively (Aucher et al. 2004). The mesF,
located between the ABC transporter mesCDE and mesHB, encodes a putative induction
factor for the bacteriocin production (Aucher et al. 2004). Likewise, the possibly secreted
YaiI may also play a role in the leucocin production in Ln. carnosum 4010.
Interestingly, further sequence analysis revealed that on the leucocin A plasmid pLC-2
there was no transporter gene anywhere close to the lcnAB genes, but only a truncated
gene tra8 encoding transposase (unpublished, Figure 3). Strain 4010 was shown to
produce leucocins A, B, and C, all of which kills Ln. pseudomesenteroides CIP103316
(II).  Resistant  colonies  were  obtained  from  the  inhibition  zone  of  leucocin  C  on  a Ln.
pseudomesenteroides CIP103316 indicator plate. The leucocin C resistant mutant was
shown to be resistant also to leucocin A, but still sensitive to leucocin B, therefore named
ACR. Via plasmid curing, ∆pLC-1 and ∆pLC-1&2 strains were generated from Ln.
carnosum 4010. Neither of the plasmid cured strain killed the indicators. Without the pLC-
1 plasmid, the strain seemed to have stopped producing leucocin A, even though the
genetic determinants of LcnA were intact in the strain (unpublished, Figures 4 & 5). These
observations indicated that LecXTS might be the solo transporter for all three leucocins in
Ln. carnosum 4010. There are a few other examples of ABC transporter, which can secrete
multiple peptides. For instance, in Lb. plantarum  at the pln loci, there is only one operon
for the ABC transporter, but the strain can produce the four bacteriocin peptides of class
IIb bacteriocins plantaricin EF and JK (Diep et al. 2009). Similarly in E. faecium NKR-5-
3, a wide-range ABC transporter EnkT was found to secrete four different enterocins
(Ishibashi et al. 2014). In the case of strain 4010, complementation of the ABC transporter
LecXTS and corresponding recovery of the leucocin production would support the theory.
Figure 4. Transcription of lcnA and lebBI in
wild type Ln. carnosum 4010, and plasmid-
cured strains 4010∆pLC-1 and 4010∆pLC-
1&2.  A,  PCR  fragment  of lcnA; B, PCR
fragment of lebBI; c, cDNA as PCR template;
r, isolated RNA as PCR template.
Figure 5. Bacteriocin production in native Ln.
carnosum 4010 and two plasmid-cured
derivatives Ln. carnosum ∆pLC-1 and Ln.
carnosum ∆pLC-1&2. Five µl of pasteurised
cell free supernatant from each o/n culture
were spotted. Ln. pseudomesenteroides
CIP103316 and Ln. pseudomesenteroides ACR
were used as indicators.
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2 Heterologous expression of functional proteins (I, II, III, unpublished)
Recombinant production of protein could be regarded as one of the most powerful
techniques in life sciences. The technique could provide pure desired protein, sometime
even at significantly higher yield than by the native producer. With a careful selection of
the efficiency of heterologous host cell, optimisation of transformation and production
(promoter, vector, codon usage), consideration of cell’s protein synthesis mechanism,
theoretically any proteins can be expressed in a heterologous host. Yet in practice
heterologous expression of functional proteins can be very challenging, as numerous
factors may affect the production process. For example, proteins require specific folding
manner to deliver their activities, and choosing a suitable host may facilitate this process.
Nevertheless functional protein may be harmful to the host, for instance when producing
transmembrane proteins, one has to ponder whether the host’s cell membrane can handle
the products.
2.1 Overexpression of leucocins (I, II, unpublished)
Many bacteriocins have their own leader peptides, which are functional in their native
producers. However, these native signal sequences may not necessarily function well in a
heterologous host. Therefore when dealing with heterologous production of bacteriocins,
mature bacteriocins are often fused with optimal leaders for the heterologous hosts. In this
study, the structural genes for leucocins A, B, and C were amplified from Ln. carnosum
4010 plasmids and individually fused with lactococcal signal sequence of unidentified
secreted 45-kDa protein (Usp45) in pLEB690 plasmid. Usp45 is the major sec-dependent
protein secreted by Lc. lactis. The signal peptide of Usp45 has been previously shown to
be an effective signal peptide for heterologous production of bacteriocins in Lactococcus
(van Asseldonk et al. 1990). For instance, class IIa bacteriocins enterocins A and P,
pediocin, sakacin A, enterocin A and class IId bacteriocin hiracin JM79 have been
functionally cloned as SSusp45 fusions in LAB (Borrero et al. 2011; Jiménez et al. 2014;
Li et al. 2011).
The expression of leucocins is under the control of both constitutive promoter P45 and
nisin-inducible promoter PnisZ (Figure 6a on page 36). Leucocins plasmids pLEB756,
pLEB727, and pLEB728 were transferred in either Lc. lactis MG1363 (LecC) or Lc. lactis
MG1614 (LcnA and LebB) for constitutive expression, and Lc. lactis NZ9000 (all three
leucocins) for nisin-inducible expression. The immunity protein LecI was also co-
expressed with leucocin C in the same manner (Figure 6b). With nisin induction, the
Lactococcus strains could produce noticeably more leucocins than plain constitutive
production; however, co-expression of the immunity protein had no significant effect on
bacteriocin production (I, II). The P45-PnisZ-SSusp45-lecC fragment was amplified by PCR
from pLEB728 digested with EcoRI, and inserted into EcoRI/SmaI  sites  of  pTF1  with
erythromycin selection resulting in pLEB731 (Figure 6c), which is an expression shuttle
plasmid in both Lactococcus and Escherichia.  Both Gram+ Lc. lactis and Gram- E. coli
could produce functional leucocin against indicator strain L. monocytogenes (unpublished,
Figure 7 on page 36). Since SSusp45 is not function in E. coli, the supernatant of ECO797
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does not display inhibitory effect against Listeria. However, as the bacteriocin can leak
out, ECO797 cells culture is active against the indicator. This efficient leucocin-producing
system could be used as the source of the bacteriocin in further studies of the immunity
proteins or utilisation of the bacteriocin and its heterologous producers.
Figure 6. Leucocin expression plasmids. The leucocin genes lcnA, lebB and lecC were  fused  to
signal sequence of usp45, and the expression is under the control of (a, b) nisin-inducible promoter
PnisZ with nisin selection marker NisR, or (c) constitutive promoter P45 with erythromycin selection
marker ErmR. Loop indicates transcriptional terminator.
Figure 7. Inhibition of leucocin C produced by Lc. lactis LAC409 and E. coli ECO797, compared
with wild type Ln. carnosum 4010 on L. monocytogenes MUU22 lawn. SAA594, E. coli TG1
carrying vector pTF1. LAC411, Lc. lactis MG1363 carrying vector pLEB690. Five µl concentrated
bacteriocin preparations or o/n cultures were spotted.
Lactococci are naturally resistant to class IIa bacteriocins, because these bacteriocins do
not bind to lactococcal Man-PTS, which in sensitive cells serves as the target (Kjos et al.
2009). In case of class IIa bacteriocin pediocin, co-expression of pediocin immunity gene
has significantly increased the yields of heterologous pediocin in host Lc. lactis (Arqués
et al. 2008). However, in this doctoral study, the protective effect of cognate immunity
proteins LecI and LcnB could not be seen in host strains which are naturally resistant to
leucocins (data not shown).
For constitutive gene expression, the phosphopentomutase promoter P8 has been shown
to be even stronger than the nisin promoter (Zhu et al. 2015a). Replacing P45 and PnisZ by
P8 would logically result in higher production level. Nevertheless, high expression of
bacteriocin may cause suicidal effect on the producer cells without immunity protein. Thus
suitability of a promoter and co-expression of immunity protein should be tested for the
strains to be used.
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2.2 Heterologous expression of other functional proteins (I, III, unpublished)
LecI shares 90 % identity with an immunity protein in Ln. citreum LBAE C10. Even
though the genes lebI and lecI encoding leucocins B and C immunity protein share great
similarity and consensus motifs with other bacteriocin immunity proteins,
complementation of the gene expression causing phenotype change would be a firmer
evidence. L. monocytogenes is naturally sensitive to class IIa bacteriocins including
leucocins A and C. In this study, leucocin C immunity protein LecI was fused with pepR
promoter from Lb. rhamnosus 1/6, cloned to a shuttle plasmid pTF1 and transferred into
L. monocytogenes. LecI was expressed in L. monocytogenes MUU23, which was
significantly more tolerant to the bacteriocin LecC than the vector carrying strain (I). Yet
the immunity capacity of heterologous LecI in Listeria was quite limited, as when exposed
to higher leucocin C concentration, LecI producing Listeria was as vulnerable as the non-
LecI counterpart (data not shown). The expression level of LecI was not determined,
however, theoretically stronger expression of the immunity protein could result in higher
resistance.
Interestingly, cloning and expressing leucocin B putative immunity protein LebI in Lc.
lactis was not successful in this study, despite several attempts. All obtained clones
contained wrong constructs (II). LebI matches 55 % with the mesentericin B105 immunity
protein MesH (Morisset and Frère 2002), and contains conserved regions identical to GtrA
superfamily of integral membrane proteins involved in synthesis of cell surface
polysaccharides. Unlike leucocin C immunity protein, but similarly to other GtrA
superfamily members, LebI contains 5  transmembrane spans as predicted by Phobius
(2017), a combined transmembrane topology and signal peptide prediction (Figure 8 on
page 38), or 3 spans by PHDhtm transmembrane helices prediction (PRABI 2016). The
structure of LebI might explain the difficulty of heterologous expression of this protein.
Attempts of expressing at lower level or using inducible promotor might be feasible to
provide useful hints about the putative immunity protein.
An extracellular loop of the Man-PTS IIC component has been found to be responsible
for specific targeting by class IIa bacteriocins (Kjos et al. 2010). In this doctoral study,
listerial MptC was cloned and expressed under the control of PnisZ promoter in Lc. lactis
N8 (III) and Lc. lactis NZ9000 (data not shown). MptC was cloned in the form of both
single copy chromosomal integration and plasmid-borne multiple replication. Both
versions of transformants displayed sensitivity to several class IIa bacteriocins, including
pediocin and leucocins A and C (III). As listerial MptC can form a functional Man-PTS
complex with lactococcal PtnD, expressing only the IIC component of L. monocytogenes
was sufficient to make Lc. lactis sensitive to class IIa bacteriocins.
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Figure 8. Transmembrane prediction of putative leucocin B immunity protein LebI by Phobius.
On both Listeria and MptC producing Lactococcus plates, small colonies grew inside the
bacteriocin halos, indicating that Lc. lactis can develop bacteriocin resistance same as L.
monocytogenes (III). The resistance mechanism to class IIa bacteriocins and lactococcin
A has been shown to be related to downregulation of Man-PTS expression (type 1) (Kjos
et al. 2011b). Yet in some cases, Man-PTS level maintained the same in bacteriocin-
resistant L. monocytogenes mutants (type 2). Changes in membrane composition and cell
surface charge have been regarded as the cause to the type 2 resistance mutation (Tessema
et al. 2009; Vadyvaloo et al. 2004; Vadyvaloo et al. 2002). Similarly in our study, the
bacteriocin resistant mutant Ln. pseudomesenteroides ACR displayed resistance to
leucocins A and C, and pediocin, but not to sakacin A, all of which are from the same class
IIa family (data not shown). Trinetta et al. (2012) suggested that sakacin A could break
down specific peptide bonds in the cell wall structure, which might explain the sustained
sensitivity of the strain ACR to this bacteriocin.
3 Using bacteriocin targeting mechanism in genome editing (III, unpublished)
Heterologous expression of mptC in Lc. lactis N8 made the naturally resistant strain
sensitive to class IIa bacteriocins, including leucocins A and C and pediocin. In this study,
mptC was  fused  with  PnisZ promoter and cloned to an E. coli plasmid harbouring two
homologous regions H1 and H2 to Lc. lactis N8 genome. The recombinant plasmid DNA
was integrated in Lc. lactis N8 genome, leaving two sets of homologous areas H1H2, and
in vivo expression of MptC made the strain vulnerable to the bacteriocins (III). When the
MptC-producing strain is challenged with bacteriocins in its living environment, cell
surviving mechanism is triggered to reverse the lethal effect. Since two sets of H1H2s are
left after integration, the most feasible way to eliminate mptC from the cell would be going
through another homologous recombination, during which the genomic area in between
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the two homologous areas is deleted (III, Figure 9). Hence, DCO cells could be
counterselected with class IIa bacteriocins. In this study, we succeeded to delete 17-, 22-,
33- and 35-kb chromosomal fragments from the wild-type nisin producing Lc. lactis N8
with this method. The deletion frequencies varied from about 8 to 40 % of all obtained
DCO colonies. However, the large genome deletions, including multiple deletions of non-
essential genes up to 55 kb in total neither affected the cell growth nor significantly
increased the cell’s production level of nisin (unpublished, Figure 10).
Figure 9. Scheme of using mptC-based selection/counterselection integration vector for
constructing gene knockout in Lc. lactis (not in scale). (a) Plasmid carrying two homologous regions
(H1, H2) flanking the region to be deleted in Lc. lactis N8 genome is integrated into the chromosome
at either of the homologous regions, and the integrant is selected by erythromycin resistance. The
resulting integrant becomes sensitive to class IIa bacteriocins. (b) A second recombination event at
H1 or H2 leads to the excision of the integrated plasmid. Only the cells which have lost the
integration vector can survive in the presence of class IIa bacteriocin. The second recombination at
the same homologous region (H1) as in the integration event reverts the integrant to the wild type.
If the second recombination takes place at H2, the event results in a chromosomal deletion between
H1 and H2. Chr, chromosomal DNA; diagonal stripes the region to be deleted.
Figure 10. Nisin production in wild type Lc. lactis N8 and strains with 22-kb, 33-kb, and 55-kb
genome deletions. Five µl or 2 µl cell free culture supernatants were spotted on M. luteus indicator
lawn.
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Two vital conditions are required for using this method in gene deletion: 1) the target strain
should be naturally resistant to the bacteriocin, hence a conditionally harmful MptC is
dispensable in its genome. Once the strain has taken recombinant MptC, bacteriocins
function as counterselecting agent to select DCO colonies, as the SCO cells are susceptible
to class IIa bacteriocins. As a result, the only survivor bacteria would be non-MptC
mutants. Because deletion of genomic area between H1H2 may happen at the same time
when the MptC is removed through DCO, seamless deletion can be made in the genome.
2) the strain should probably be equipped with native Man-PTS to form functional
complex with heterologous MptC. Otherwise, cloning of both MptC and MptD would be
required to make the target strain sensitive. Yet depending on which bacteriocin is used,
either/both IIC or/and IID would be needed. For example, lactococcin A requires both
regions to conduct its activity to target cell (Kjos et al. 2010).
At present, the CRISPR/Cas system, popular for genomic deletions in bacteria, has not
been reported in the use of Lactococcus genome editing. Instead, chromosomal deletions
in Lc. lactis have often been made using TS pG+ Host vectors (Biswas et al. 1993).
However, culturing Lc. lactis at a high temperature (37.5 °C) can result in stable heat
resistant mutation (Smith et al. 2012), which makes this method less suitable for
consecutive multiple genome deletions in one strain. In addition to the pG+ Host vectors,
the only reported counterselectable markers for gene deletions of LAB are the oroP gene
encoding the orotate transporter in Lc. lactis (Solem et al. 2008) and the upp gene encoding
uracil phosphoribosyltransferase in Lb. acidophilus, Lb. casei, and Lc. lactis (Goh et al.
2009; Song et al. 2014). However, as the upp gene is generally existing and expressed in
LAB, deleting upp from the host is obligatory if this counterselectable marker is used in
gene deletion. Moreover, the selecting agent 5-fluorouracial may be metabolised and thus
be toxic to the cells (Martinussen and Hammer 1994). Comparing with these two
counterselection methods, selection of the DCO colonies with bacteriocin does not require
chemically defined or semi-defined media. Commercial M17 supplemented with glucose
and class IIa bacteriocin from cell free supernatant is sufficient for obtaining a deletion
frequency of 10 to 40 % of DCO colonies.
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CONCLUSIONS AND FUTURE PROSPECTS
In this thesis, the main targets were to genetically characterise and to overexpress
Leuconostoc bacteriocins leucocins A, B, and C, and to apply the bacteriocins in genome
editing. The genes required for the production of the three leucocins from Ln. carnosum
4010 were shown to be plasmid-borne, with leucocin A genetic determinants lcnAB on
one plasmid and leucocins B and C determinants lebBI and lecCI on another. LecI was
shown to protect the strain from its cognate bacteriocin leucocin C. According to the RT-
PCR analysis, lebI is co-expressed with the bacteriocin gene lebB in Ln. carnosum 4010.
However, heterologous expression of LebI was not successful, possibly due to its
transmembrane spans. Therefore, optimisation of expression would be needed to produce
the protein in a leucocin B sensitive host. In addition to the bacteriocin and the immunity
genes, lecXTS genes encoding the ABC transporter were also identified. Since only one
ABC transporter was found, this transporter may be responsible for secreting all three
leucocins in Ln. carnosum 4010. Inactivation of transporter and restoration of the
bacteriocin production by complementation would confirm the function of LecXTS.
Bacteriocins have the potential to prolong the shelf life of food products by eliminating
spoilage and pathogenic bacteria. Hence, overexpression of bacteriocins in different hosts
would provide a good tool for food biopreservation. Here, LcnA, LebB and LecC were
produced by heterologous hosts E. coli and Lc. lactis.  The  latter  was  shown  to  be  an
excellent host for leucocin production; the production levels were comparable to the native
producer. These leucocin producing Lc. lactis strains could be used for food and research
applications.
The killing mechanism of class IIa bacteriocins relies on Man-PTS on the target cell
membrane. Man-PTS is not only responsible for transporting and catalysing
phosphorylation of incoming sugar, but also providing a target for the bacteriocins to bind.
Expressing the Man-PTS component IIC (MptC) from L. monocytogenes in Lc. lactis
rendered the latter sensitive to class IIa bacteriocins. Using this acquired sensitivity, a
counterselection system was developed for chromosomal deletions in Lc. lactis. A plasmid
carrying mptC was constructed and integrated into Lc. lactis genome. With bacteriocin
selection, the cells which had lost the mptC plasmid through DCO could easily be found.
In addition to the loss of the plasmid, some DCO cells had also deleted the target region
in the chromosome. However, in certain cases the vast majority of the obtained DCO
colonies can be wild-type revertants, which leads to extensive screening for the wanted
deletion. Therefore, a method selecting only the deletion would be even better. Still, the
counterselection method developed in this study makes Lc. lactis genome editing much
easier. Several large deletions, up to 35 kb, were created using leucocin selection. By
deleting, inserting, or mutating genes in bacterial chromosome, it is possible to generate
new strains with different properties, e.g. increased production of desired compounds.
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